Total Payments
$15,199
2024 Payments
$1,662
Companies
45
Transactions
529
Medicare Patients
2,044
Medicare Billing
$228,584
Payment Breakdown by Category
Food & Beverage$12,655 (83.3%)
Other$2,500 (16.4%)
Education$22.68 (0.1%)
Travel$21.11 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,655 | 525 | 83.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 16.4% |
| Education | $22.68 | 2 | 0.1% |
| Travel and Lodging | $21.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $3,290 | 19 | $0 (2023) |
| ABBVIE INC. | $1,879 | 96 | $0 (2024) |
| Covidien LP | $1,709 | 28 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,366 | 103 | $0 (2024) |
| Janssen Biotech, Inc. | $998.00 | 45 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $750.19 | 37 | $0 (2024) |
| Gilead Sciences, Inc. | $686.10 | 24 | $0 (2021) |
| Allergan, Inc. | $457.49 | 19 | $0 (2020) |
| PFIZER INC. | $456.44 | 23 | $0 (2024) |
| QOL Medical, LLC | $346.68 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,662 | 70 | Takeda Pharmaceuticals U.S.A., Inc. ($287.43) |
| 2023 | $1,865 | 76 | AbbVie Inc. ($364.06) |
| 2022 | $1,190 | 78 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($313.50) |
| 2021 | $1,395 | 80 | AbbVie Inc. ($355.83) |
| 2020 | $1,191 | 47 | GI Supply, Inc. ($240.39) |
| 2019 | $1,142 | 54 | Allergan Inc. ($207.62) |
| 2018 | $2,558 | 61 | Covidien LP ($955.55) |
| 2017 | $4,196 | 63 | BOSTON SCIENTIFIC CORPORATION ($2,718) |
All Payment Transactions
529 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.84 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.36 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Immunology | ||||||
| 10/08/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/02/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 475 | 523 | $295,191 | $54,177 |
| 2022 | 12 | 476 | 516 | $275,755 | $51,978 |
| 2021 | 13 | 715 | 800 | $378,745 | $81,106 |
| 2020 | 11 | 378 | 427 | $181,100 | $41,323 |
Total Patients
2,044
Total Services
2,266
Medicare Billing
$228,584
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $23,700 | $9,134 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 99 | $22,350 | $8,773 | 39.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $54,600 | $7,641 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 86 | $64,500 | $6,525 | 10.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 53 | 53 | $68,900 | $6,310 | 9.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 34 | 34 | $34,000 | $4,357 | 12.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 36 | $7,200 | $3,579 | 49.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $7,491 | $2,453 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $4,500 | $2,173 | 48.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 25 | $3,750 | $1,653 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 24 | $4,200 | $1,578 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $20,400 | $8,554 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 77 | $17,325 | $7,110 | 41.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 59 | 59 | $76,700 | $7,023 | 9.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 42 | 42 | $42,000 | $5,898 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 69 | $51,750 | $5,497 | 10.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 23 | 23 | $32,200 | $4,282 | 13.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $7,500 | $4,142 | 55.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 33 | $6,600 | $2,755 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $9,940 | $2,646 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 36 | $6,300 | $2,340 | 37.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 28 | $4,200 | $1,673 | 39.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 12 | 12 | $840.00 | $59.53 | 7.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 120 | 120 | $36,000 | $15,823 | 44.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 54 | 61 | $18,300 | $10,287 | 56.2% |
About Dr. Carl Atallah, DO
Dr. Carl Atallah, DO is a Gastroenterology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1922269190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Atallah, DO has received a total of $15,199 in payments from pharmaceutical and medical device companies, with $1,662 received in 2024. These payments were reported across 529 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($12,655).
As a Medicare-enrolled provider, Atallah has provided services to 2,044 Medicare beneficiaries, totaling 2,266 services with total Medicare billing of $228,584. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Chicago, IL
- Active Since 06/20/2008
- Last Updated 04/08/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1922269190
Products in Payments
- WATCHMAN (Device) $2,917
- XIFAXAN (Drug) $980.49
- STELARA (Biological) $761.61
- ENTYVIO (Biological) $513.14
- LINZESS (Drug) $444.26
- PillCam (Device) $427.38
- ZEPOSIA (Drug) $382.67
- Beacon (Device) $337.65
- XELJANZ (Drug) $331.52
- Barrx (Device) $326.17
- RINVOQ (Biological) $296.87
- VIBERZI (Drug) $285.17
- CREON (Drug) $267.44
- Epclusa (Drug) $247.23
- SKYRIZI (Biological) $221.44
- DUPIXENT (Biological) $206.60
- Manometry (Device) $195.83
- Trulance (Drug) $191.50
- SUCRAID (Drug) $186.51
- REMICADE (Biological) $179.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Chicago
Stephen Hanauer, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
David Rubin
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Darren Brenner, M.d, M.D
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Steven Flamm, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Russell Cohen
Gastroenterology — Payments: $834,887
Gastroenterology $834,887
Atman Shah
Gastroenterology — Payments: $766,122
Gastroenterology $766,122